Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
February 19, 2026 Off

Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026

By BusinessWire

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article…

February 19, 2026 Off

Hana Health by DSS Imagetech Partners with Overture Life to Bring World-First Automated Egg-Freezing Technology to India

By BusinessWire

DaVitri is an automated egg-freezing platform that enables fertility clinics to standardize one of the most technically demanding steps in…

February 19, 2026 Off

Compass Pathways Announces Pricing of $150 Million Public Offering

By BusinessWire

LONDON & NEW YORK–(BUSINESS WIRE)–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation,…

February 19, 2026 Off

Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

By GlobeNewswire

GREENSBORO, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) — Precise Bio, Inc. (“Precise Bio” or the “Company”), a clinical-stage regenerative medicine…

February 19, 2026 Off

XOMA Royalty to Present at Investor Conferences in March

By GlobeNewswire

EMERYVILLE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members…

February 19, 2026 Off

Aptar to Participate in Upcoming Investor Conferences

By BusinessWire

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection…

February 19, 2026 Off

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call

By BusinessWire

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced it will host its fourth quarter and full year 2025 investor update…

February 19, 2026 Off

IQVIA to Speak at Citi’s 2026 Unplugged MedTech and Life Sciences Access Day

By BusinessWire

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and…

February 18, 2026 Off

Ankyra Therapeutics Presents First Preclinical Data on ANK-203, a Novel CD137-Anchored Immunotherapy Candidate, in Oral Session at AACR IO

By BusinessWire

ANK-203 is a first-in-class anchored immunotherapy designed to unlock the full therapeutic potential of monoclonal antibody CD137 through localized delivery…

February 18, 2026 Off

Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development

By BusinessWire

BAAR, Switzerland–(BUSINESS WIRE)–Evinova today announced strategic collaborations with global life sciences companies Astellas Pharma Inc. (“Astellas”), AstraZeneca and Bristol Myers…

Posts pagination

Previous 1 … 3 4 5 … 6,330 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 19, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine